Developing Novel Therapeutic Strategies for Pancreatic Cancer using Targets Identified by Next Generation Sequencing [ 2012 - 2017 ]

Research Grant

Researchers: Dr David Chang (Principal investigator)

Brief description Dr David Chang is a surgeon scientist who specialises in the treatment of pancreatic cancer. His research focus is on the development and implementation of novel therapeutic strategies for pancreatic cancer. He aims to achieve this by utilising novel biomarkers that have the ability to forecast prognosis and response to treatments. Ultimately, this will lead to the “individualised” treatment for each patient.

Funding Amount $AUD 373,614.65

Funding Scheme Early Career Fellowships

Notes Peter Doherty Biomedical ECF